TrialJournal for immunotherapy of cancer2023

New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors.

Aristotelis Bamias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.